Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery.
<h4>Background</h4>Experimental cardiac ischemia-reperfusion injury causes degradation of the glycocalyx and coronary washout of its components syndecan-1 and heparan sulfate. Systemic elevation of syndecan-1 and heparan sulfate is well described in cardiac surgery. Still, the events dur...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0251747 |
id |
doaj-18a50d08e77d467eaad0942048228ec3 |
---|---|
record_format |
Article |
spelling |
doaj-18a50d08e77d467eaad0942048228ec32021-05-30T04:30:44ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01165e025174710.1371/journal.pone.0251747Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery.Arie PassovAlexey SchramkoUlla-Stina SalminenJuha AittomäkiSture AnderssonEero Pesonen<h4>Background</h4>Experimental cardiac ischemia-reperfusion injury causes degradation of the glycocalyx and coronary washout of its components syndecan-1 and heparan sulfate. Systemic elevation of syndecan-1 and heparan sulfate is well described in cardiac surgery. Still, the events during immediate reperfusion after aortic declamping are unknown both in the systemic and in the coronary circulation.<h4>Methods</h4>In thirty patients undergoing aortic valve replacement, arterial concentrations of syndecan-1 and heparan sulfate were measured immediately before and at one, five and ten minutes after aortic declamping (reperfusion). Parallel blood samples were drawn from the coronary sinus to calculate trans-coronary gradients (coronary sinus-artery).<h4>Results</h4>Compared with immediately before aortic declamping, arterial syndecan-1 increased by 18% [253.8 (151.6-372.0) ng/ml vs. 299.1 (172.0-713.7) ng/ml, p < 0.001] but arterial heparan sulfate decreased by 14% [148.1 (135.7-161.7) ng/ml vs. 128.0 (119.0-138.2) ng/ml, p < 0.001] at one minute after aortic declamping. There was no coronary washout of syndecan-1 or heparan sulfate during reperfusion. On the contrary, trans-coronary sequestration of syndecan-1 occurred at five [-12.96 ng/ml (-36.38-5.15), p = 0.007] and at ten minutes [-12.37 ng/ml (-31.80-6.62), p = 0.049] after reperfusion.<h4>Conclusions</h4>Aortic declamping resulted in extracardiac syndecan-1 release and extracardiac heparan sulfate sequestration. Syndecan-1 was sequestered in the coronary circulation during early reperfusion. Glycocalyx has been shown to degrade during cardiac surgery. Besides degradation, glycocalyx has propensity for regeneration. The present results of syndecan-1 and heparan sulfate sequestration may reflect endogenous restoration of the damaged glycocalyx in open heart surgery.https://doi.org/10.1371/journal.pone.0251747 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Arie Passov Alexey Schramko Ulla-Stina Salminen Juha Aittomäki Sture Andersson Eero Pesonen |
spellingShingle |
Arie Passov Alexey Schramko Ulla-Stina Salminen Juha Aittomäki Sture Andersson Eero Pesonen Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery. PLoS ONE |
author_facet |
Arie Passov Alexey Schramko Ulla-Stina Salminen Juha Aittomäki Sture Andersson Eero Pesonen |
author_sort |
Arie Passov |
title |
Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery. |
title_short |
Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery. |
title_full |
Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery. |
title_fullStr |
Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery. |
title_full_unstemmed |
Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery. |
title_sort |
endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2021-01-01 |
description |
<h4>Background</h4>Experimental cardiac ischemia-reperfusion injury causes degradation of the glycocalyx and coronary washout of its components syndecan-1 and heparan sulfate. Systemic elevation of syndecan-1 and heparan sulfate is well described in cardiac surgery. Still, the events during immediate reperfusion after aortic declamping are unknown both in the systemic and in the coronary circulation.<h4>Methods</h4>In thirty patients undergoing aortic valve replacement, arterial concentrations of syndecan-1 and heparan sulfate were measured immediately before and at one, five and ten minutes after aortic declamping (reperfusion). Parallel blood samples were drawn from the coronary sinus to calculate trans-coronary gradients (coronary sinus-artery).<h4>Results</h4>Compared with immediately before aortic declamping, arterial syndecan-1 increased by 18% [253.8 (151.6-372.0) ng/ml vs. 299.1 (172.0-713.7) ng/ml, p < 0.001] but arterial heparan sulfate decreased by 14% [148.1 (135.7-161.7) ng/ml vs. 128.0 (119.0-138.2) ng/ml, p < 0.001] at one minute after aortic declamping. There was no coronary washout of syndecan-1 or heparan sulfate during reperfusion. On the contrary, trans-coronary sequestration of syndecan-1 occurred at five [-12.96 ng/ml (-36.38-5.15), p = 0.007] and at ten minutes [-12.37 ng/ml (-31.80-6.62), p = 0.049] after reperfusion.<h4>Conclusions</h4>Aortic declamping resulted in extracardiac syndecan-1 release and extracardiac heparan sulfate sequestration. Syndecan-1 was sequestered in the coronary circulation during early reperfusion. Glycocalyx has been shown to degrade during cardiac surgery. Besides degradation, glycocalyx has propensity for regeneration. The present results of syndecan-1 and heparan sulfate sequestration may reflect endogenous restoration of the damaged glycocalyx in open heart surgery. |
url |
https://doi.org/10.1371/journal.pone.0251747 |
work_keys_str_mv |
AT ariepassov endothelialglycocalyxduringearlyreperfusioninpatientsundergoingcardiacsurgery AT alexeyschramko endothelialglycocalyxduringearlyreperfusioninpatientsundergoingcardiacsurgery AT ullastinasalminen endothelialglycocalyxduringearlyreperfusioninpatientsundergoingcardiacsurgery AT juhaaittomaki endothelialglycocalyxduringearlyreperfusioninpatientsundergoingcardiacsurgery AT stureandersson endothelialglycocalyxduringearlyreperfusioninpatientsundergoingcardiacsurgery AT eeropesonen endothelialglycocalyxduringearlyreperfusioninpatientsundergoingcardiacsurgery |
_version_ |
1721421166819672064 |